期刊文献+

Tim-3及其配体Gal-9与宫颈鳞状细胞癌病理分级和预后的相关性研究 被引量:2

Study on the Correlation of Tim-3 and Its Ligand Gal-9 with Pathological Grading and Prognosis in Squamous Cell carcinoma of the Cervix
下载PDF
导出
摘要 目的探究不同病理分级的宫颈鳞状细胞癌患者血清及癌组织中T细胞免疫球蛋白黏蛋白3(Tim-3)及其配体半乳凝素9(Gal-9)表达,分析其临床意义。方法收集17例上皮瘤样病变(CIN),38例含低(PSCC)、中(MSCC)、高分化(WSCC)宫颈鳞状细胞癌(SCC)组织以及血清样本,17例正常妇女血清,并依次分为CIN组、PSCC组、MSCC组、WSCC组以及正常组。分别采用蛋白质免疫杂交技术(Western blot)以及q RT-PCR技术检测CIN组、PSCC组、MSCC组以及WSCC组组织样本中Tim-3以及Gal-9的表达,采用酶联免疫吸附法(ELISA)检测CIN组、PSCC组、MSCC组、WSCC组以及正常组血清样本中Gal-9的表达水平。分别比较各组组织中Tim-3和Gal-9的表达以及血清中Gal-9的表达水平与宫颈鳞状细胞癌不同病理分级的相关性。结果 Western blot与q RT-PCR结果均显示Tim-3和Gal-9在SCC各组组织中表达高于CIN组(P<0.05),且与病理分级呈正相关(r=0.738、0.671,P<0.05)。ELISA结果亦显示Gal-9在SCC各组血清中高于正常组以及CIN组(P<0.05),切与病理分级呈正相关性(r=0.687,P<0.05)。结论 Tim-3及其配体Gal-9的表达与宫颈鳞状细胞癌病理分级成正相关,Tim-3以及Gal-9可作为临床诊断及预后的有义指标。 Objective Our study investigates the expression of T cell immunoglobulin mucin 3(Tim-3) and its ligand galectin-9(Gal-9) in the serum and cancer tissue in patients with squamous cell carcinoma of the cervix of different pathological gradings and analyzes its clinical significance. Methods We collected the samples of tissues and serum of 17 cases of cervical intraepithelial neoplasia(CIN), 38 cases of squamous cell carcinoma(SCC) of the cervix including poorly differentiated squamous cell carcino-ma(PSCC) of the cervix, moderately differentiated squamous cell carcinoma(MSCC) of the cervix, well differentiated squamous cell carcinoma(WSCC) of the cervix, and 17 cases of normal women and grouped them as the CIN group, PSCC group, MSCC group,WSCC group, normal group in turn. The expressions of Tim-3 and Gal-9 in the tissues of CIN, PSCC, MSCC, WSCC group detected by Western blot and q RT-PCR were compared between the groups and the expressions of Gal-9 in the serum of the above groups and the normal group detected by ELISA were also compared between the groups so as to find the correlation between their expressions and pathological grading of squamous cell carcinoma of the cervix. Results The result of Western blot and q RT-PCR showed that Tim-3 and Gal-9 expression in the tissues of SCC groups were higher than that in the CIN group(P〈0.05), and Tim-3and Gal-9 had positive correlation with pathological gradings(r=0.738, 0.671, P〈0.05). The result of ELISA showed that the expression of Gal-9 in the serum of SCC groups was higher than that in the normal group and CIN group(P〈0.05), and Gal-9 had positive correlation with pathological gradings(r=0.687, P〈0.05). Conclusion The expression of Tim-3 and its ligand Gal-9 has positive correlation with the pathological gradings of squamous cell carcinoma of the cervix. Tim-3 and Gal-9 can be the significant indicators of clinical diagnosis and prognosis.
出处 《中外医疗》 2014年第28期63-65,共3页 China & Foreign Medical Treatment
基金 广东省医学科研基金课题(A2013757)
关键词 宫颈鳞状细胞癌 病理分级 TIM-3 Gal-9 Squamous cell carcinoma of the cervix Pathological grading Tim-3 Gal-9
  • 相关文献

参考文献10

  • 1Freeman GJ,Casasnovas JM,Umetsu DT,et al.TIM genes:afamilyof cell surface phosphatidylserine receptors that regulate in-nate and adaptive immunity.Immunol Rev[J].2010,235(1):172-189.
  • 2Anderson,Ana Carrizosa.Tim-3,a negative regulator of anti-tumor immunity.Current Opinion in Immunology[J].2012,24(4):213-216.
  • 3Keiko Nagahara,Tomohiro Arikawa,Souichi Oomizu,et al.Galectin-9 increases Tim-3 dendritic cellsand CD8T cellsand enhances antitumor immunityvia galectin-9-Tim-3 interactions.The Journalof Immunology[J].2008,181(8):7660-7669.
  • 4Kuchroo VK,Dardalhon V,Xiao S,et al.New roles for TIM family members in immune regulation[J].Nat Rev Immunol,2008,8(8):577-580.
  • 5赵国栋,朴勇瑞.TIM-3在前列腺癌中的表达及其意义[J].实用医学杂志,2014,30(8):1241-1244. 被引量:8
  • 6Jan M,Chao MP,Cha AC,et al.Prospective separation of normal and leukemic stem cells based on differential expression of Tim-3,a human acute myeloid leukemia stem cell marker[J].Proc Natl Acad Sci,2011,108(12):5009-5014.
  • 7KIkushige Y,Shima T,Takayanagi S,et al.Tim-3 is a promising target to selectively kill acute myeloid leukemia stem cells[J].Cell Stem Cell,2010,7(6):708-717.
  • 8Wiener Z,Kohalmi B,Pocza P,et al.Tim-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells[J].J Invest Dermatol,2007,127(4):906-914.
  • 9Meiyan L,Masaki U,Souichi O,et al.Galectin-9 expression links to malignant potential of cervical aquamous cell carcinoma[J].J Cancer Res Clin Oncol,2008,134(2):899-907.
  • 10梁美艳,鲁艳明,张瑶,张淑兰.子宫颈癌患者血清中半乳凝素9的检测及临床意义[J].中华医学杂志,2008,88(39):2783-2785. 被引量:8

二级参考文献24

  • 1Hakomori SI. Inaugural article:the glycosynapse. Proc Natl Acad Sci U S A, 2002, 99: 225-232.
  • 2Elola MT, Wolfenstein-Todel C, Troncoso MF, et al. Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell Mol Life Sci, 2007, 64: 1679- 1700.
  • 3Kuwabara I, Sano H, Liu FT. Functions of galectins in cell adhesion and chemotaxis. Methods Enzymol, 2003, 363: 532- 552.
  • 4Liang M, Ueno M, Oomizu S, et al. Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma. J Cancer Res Clin Oncol, 2008, 134: 899-907.
  • 5Kohrenhagen N, Volker HU, Kapp M, et al. Increased expression of galectin-1 during the progression of cervical neoplasia, lnt J Gynecol Cancer, 2006, 16: 2018-2022.
  • 6Lee JW, Song SY, Choi JJ, et al. Decreased galectin-3 expression during the progression of cervical neoplasia. J Cancer Res Clin Oncol, 2006, 132 : 241-247.
  • 7Kageshita T, Kashio Y, Yamauchi A, et al. Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer, 2002, 99: 809-816.
  • 8Yamauchi A, Kontani K, Kihara M, et al. Galectin-9, a novel prognostic factor with antimetastatic potential in breast cancer. Breast J, 2006, 12: 196-200.
  • 9Jemal A, Siegel R, Xu J, et al. Cancer statistics [J]. CA Can- cer J Clin, 2010,60(5) :277 -300.
  • 10Sugiyama Y, Masumori N, Fukuta F, et al. Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk [J]. Asian Pac J Cancer Prey, 2013, 14( 1 ) : 1-4.

共引文献14

同被引文献33

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部